These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1294610)

  • 1. [Prevalence of eye diseases in Basedow disease. Apropos of a prospective study with 85 cases].
    Vangheluwe O; Ducasse A; Vaudrey C; Maes B; Delisle MJ; Segal A
    J Fr Ophtalmol; 1992; 15(8-9):469-73. PubMed ID: 1294610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of ophthalmopathy in Basedow disease. Follow-up of patients one year following diagnosis of hyperthyroidism].
    Vangheluwe O; Ducasse A; Vaudrey C; Maes B; Delisle MJ
    J Fr Ophtalmol; 1994; 17(5):331-8. PubMed ID: 8089419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined cyclosporin-A and methylprednisolone treatment of Graves' ophthalmopathy.
    Leövey A; Bakó G; Szabó J; Kálmán K; Fórizs E
    Acta Med Hung; 1992-1993; 49(3-4):179-85. PubMed ID: 1345455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
    Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
    Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy?
    Maurer E; Dănilă R; Dominguez E; Osei-Agymang T; Zielke A; Hassan I
    Chirurgia (Bucur); 2008; 103(3):291-5. PubMed ID: 18717277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of treatment of progressive edematous infiltrative ophthalmopathy on intraocular pressure].
    Rutecka-Debniak A; Krzystolik Z; Pilarska K; Krzyzanowska-Swiniarska B; Syrenicz A; Jarema A
    Klin Oczna; 1999; 101(3):195-200. PubMed ID: 10526444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dysthyroid optic neuropathy. Apropos of 2 cases].
    Domenjôd M; Merle H; Gerard M; Ayeboua L; Poman G
    J Fr Ophtalmol; 1996; 19(8-9):543-50. PubMed ID: 8944137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' ophthalmopathy--a clinical review.
    Carter JN
    Aust N Z J Ophthalmol; 1990 Aug; 18(3):239-42. PubMed ID: 2261168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for occurrence of ophthalmopathy in the course of Graves-Basedow disease].
    Sieradzki J; Katra B; Mirkiewicz-Sieradzka B
    Przegl Lek; 2000; 57(6):321-3. PubMed ID: 11107864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' thyroid ophthalmopathy in Ethiopian patients.
    Teshome T; Seyoum B
    Ethiop Med J; 2001 Jan; 39(1):1-8. PubMed ID: 11338463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Graves' ophthalmopathy--a prospective clinical study].
    Bogdănici C; Marcu C
    Oftalmologia; 1999; 48(3):19-22, 25. PubMed ID: 10641113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation of Graves' ophthalmopathy.
    Wiersinga WM; Smit T; van der Gaag R; Mourits M; Koornneef L
    Ophthalmic Res; 1989; 21(2):73-82. PubMed ID: 2786616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
    Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenetic connection between Graves' disease and chronic lymphocytic thyroiditis. (The role and incidence of thyroid stimulating antibodies).
    Leövey A; Bakó G; Sztojka I; Bordán L; Szabó T; Kálmán K; Balázs C
    Acta Med Acad Sci Hung; 1982; 39(1-2):1-6. PubMed ID: 6129766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What the internist should know about the ophthalmopathy of Graves' disease.
    Hamburger JI; Sugar HS
    Arch Intern Med; 1972 Jan; 129(1):131-9. PubMed ID: 5066655
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA-DR associations with Graves' disease in eastern Hungary.
    Stenszky V; Kozma L; Balazs C; Farid NR
    Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracentral corneal dellen: a rare sign of Graves ophthalmopathy.
    Yan J; Wu Z
    Yan Ke Xue Bao; 2003 Sep; 19(3):174-5. PubMed ID: 14574976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.